About 1 Mg Anastrozole Tablets IP
Experience the exquisite benefits of 1 Mg Anastrozole Tablets IP, a monumental breakthrough in hormone therapy for breast cancer treatment in postmenopausal women. These blister-packed tablets deliver sizzling efficacy with a non-steroidal, aromatase-inhibiting mechanism, ensuring precise, once-daily targeting. The special, film-coated round tablets display a ravishing white to off-white finish, offering odorless, immediate-release dosing. Each strip or pack is meticulously protected for 24 months, maintaining their ephemeral potency. Designed exclusively for oral administration, this product is not for premenopausal use or during pregnancy and lactation.
Targeted Action for Postmenopausal Breast Cancer
1 Mg Anastrozole Tablets IP showcase a special surface application, enabling efficient oral hormone therapy. With monumental efficacy in inhibiting the aromatase enzyme, it promises ravishing results for postmenopausal women battling breast cancer. Extra features include odorless formulation, immediate-release dosage, and precise tablet markings. The targeted approach ensures sizzling convenience with once-daily use, helping users experience an exquisite aid in cancer management.
Sample Availability and Packaging Excellence
Secure your proposal amount and purchase order for 1 Mg Anastrozole Tablets IP samples, available in blister packs (1 x 10 or 1 x 30 tablets). Arrival timelines depend on distributor logistics. Packaging details ensure protection from moisture and light, maintaining integrity below 30C. Certifications and product registration numbers are provided per local regulatory authority. Prompt shipment from India, with rigorous quality control, guarantees monumental confidence in every trade transaction.
FAQ's of 1 Mg Anastrozole Tablets IP:
Q: How is 1 Mg Anastrozole Tablets IP used for breast cancer therapy?
A: This tablet is taken orally, once daily, and is designed to inhibit the aromatase enzyme, making it highly effective for hormone therapy in postmenopausal women with breast cancer.
Q: What are the special tablet features and markings?
A: Each tablet is round, film-coated, white to off-white, and may include a single mark on one side, referencing supplied images for identification.
Q: When should this medication not be used?
A: It is contraindicated in premenopausal women, and should not be used during pregnancy or lactation due to potential risks.
Q: Where can I find packaging and regulatory details for this product?
A: Packaging comes in blister strips or packs, with product registration numbers provided as per local regulatory authorities. Distribution is managed regionally in India.
Q: What is the process for acquiring sample tablets?
A: Submit a purchase order and proposal amount. Samples are shipped per distributor schedules, with detailed packaging and arrival timelines confirmed at order acceptance.
Q: What benefit does Anastrozole offer over other hormone therapies?
A: It functions as a non-steroidal aromatase inhibitor, providing an exquisite, immediate-release effect while reducing hormone levels that fuel certain breast cancers in postmenopausal patients.